ClinicalTrials.gov
public full text
Public Domain
Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions
Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer#886107
- Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer#1173585
- Intratumoral PH-762 for Cutaneous Carcinoma#803309
- TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers#847069
- Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery#846558
Record · ID 968366
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive